Cita APA (7a ed.)

M, J., G, B., & HR, H. 3. (2013). Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US. Dove Medical Press.

Cita Chicago Style (17a ed.)

M, Jara, Barker G, y Henney 3rd HR. Dalfampridine Extended Release Tablets: 1 Year of Postmarketing Safety Experience in the US. Dove Medical Press, 2013.

Cita MLA (8a ed.)

M, Jara, et al. Dalfampridine Extended Release Tablets: 1 Year of Postmarketing Safety Experience in the US. Dove Medical Press, 2013.